ArticlePloS one2025
Development of the advised protocol for OCT study terminology and elements anterior segment OCT extension reporting guidelines (APOSTEL-AS): Study protocol.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- High-Resolution Anterior Segment Optical Coherence Tomography Characteristics of Conjunctival Tumors.Journal of clinical practice and research · 2026Article
- Anterior Segment Optical Coherence Tomography with Angiography for the Cornea and Ocular Surface.Journal of clinical medicine · 2026Review
- Proposed Nomenclature for Landmarks in Anterior-Segment OCT: The APOSTEL-AS Panel Consensus.JAMA ophthalmology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
backgroundAnterior segment optical coherence tomography (AS-OCT) is emerging as a valuable diagnostic, monitoring and predictive tool. Clinical utility has been suggested for ophthalmic disorders such as glaucoma, corneal disease, cataract and uveitis, which taken together comprise the majority of the blinding conditions affecting working age individuals globally. anterior segment is an obstacle to reproducibility and interoperability. To provide this guidance, we aim to extend the existing Advised Protocol for OCT Study Terminology and Elements (APOSTEL) guidelines, to ensure applicability to AS-OCT.
methodsIn line with EQUATOR Network guidance for the development of reporting guidelines, APOSTEL-AS will be developed through a staged consensus process involving literature review and Delphi consensus across an international multi-disciplinary stakeholder group, overseen by a multi-disciplinary multi-national Steering Committee. The systematic scoping review will be used to generate candidate items, support the development of a consensus nomenclature for AS-OCT representation of ocular structure, and to form Delphi group membership. Delphi methodology, used to consider items for inclusion, rewording or exclusion, will be undertaken in line with ACCORD (ACcurate COnsensus Reporting Document) guidance, with at least two rounds of Delphi survey, inclusion consensus threshold set at 80%, and steering committee reviews between rounds. The resultant APOSTEL-AS guideline will undergo piloting before dissemination of the final version. DISCUSSION: The APOSTEL-AS checklist, with minimum and recommended items to be reported about study methods, should provide timely support for researchers to ensure future standardisation, interoperability and reproducibility of reported work, hastening implementation and the translation of knowledge into clinically beneficial action.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.